首页> 外文期刊>Radiology >Radiologic-pathologic analysis of contrast-enhanced and diffusion-weighted mr imaging in patients with HCC after TACE: Diagnostic accuracy of 3D quantitative image analysis
【24h】

Radiologic-pathologic analysis of contrast-enhanced and diffusion-weighted mr imaging in patients with HCC after TACE: Diagnostic accuracy of 3D quantitative image analysis

机译:TACE后HCC的增强和弥散加权磁共振成像的放射病理学分析:3D定量图像分析的诊断准确性

获取原文
获取原文并翻译 | 示例

摘要

Purpose: To evaluate the diagnostic performance of three-dimensional (3D) quantitative enhancement-based and diffusionweighted volumetric magnetic resonance (MR) imaging assessment of hepatocellular carcinoma (HCC) lesions in determining the extent of pathologic tumor necrosis after transarterial chemoembolization (TACE).Materials and Methods: This institutional review board-approved retrospective study included 17 patients with HCC who underwent TACE before surgery. Semiautomatic 3D volumetric segmentation of target lesions was performed at the last MR examination before orthotopic liver transplantation or surgical resection. The amount of necrotic tumor tissue on contrast material-enhanced arterial phase MR images and the amount of diffusion-restricted tumor tissue on apparent diffusion coefficient (ADC) maps were expressed as a percentage of the total tumor volume. Visual assessment of the extent of tumor necrosis and tumor response according to European Association for the Study of the Liver (EASL) criteria was performed. Pathologic tumor necrosis was quantified by using slide-byslide segmentation. Correlation analysis was performed to evaluate the predictive values of the radiologic techniques.Results: At histopathologic examination, the mean percentage of tumor necrosis was 70% (range, 10%-100%). Both 3D quantitative techniques demonstrated a strong correlation with tumor necrosis at pathologic examination (R2 = 0.9657 and R2 = 0.9662 for quantitative EASL and quantitative ADC, respectively) and a strong intermethod agreement (R2 = 0.9585). Both methods showed a significantly lower discrepancy with pathologically measured necrosis (residual standard error [RSE] = 6.38 and 6.33 for quantitative EASL and quantitative ADC, respectively), when compared with non-3D techniques (RSE = 12.18 for visual assessment).Conclusion: This radiologic-pathologic correlation study demonstrates the diagnostic accuracy of 3D quantitative MR imaging techniques in identifying pathologically measured tumor necrosis in HCC lesions treated with TACE.
机译:目的:评估基于3D(3D)定量增强和弥散加权体积磁共振(MR)成像对肝细胞癌(HCC)病变的诊断性能,以确定经动脉化疗栓塞(TACE)后病理性肿瘤坏死的程度。资料和方法:这项经机构审查委员会批准的回顾性研究包括17例HCC患者,这些患者在手术前接受了TACE。在原位肝移植或手术切除前的最后一次MR检查中对目标病变进行半自动3D体积分割。造影剂增强的动脉期MR图像上的坏死肿瘤组织的数量和表观扩散系数(ADC)图上的扩散受限的肿瘤组织的数量表示为总肿瘤体积的百分比。根据欧洲肝病研究协会(EASL)标准,目测评估肿瘤坏死程度和肿瘤反应。病理肿瘤坏死定量使用幻灯片逐段分割。结果:在组织病理学检查中,肿瘤坏死的平均百分比为70%(范围为10%-100%)。两种3D定量技术在病理学检查中均与肿瘤坏死密切相关(对于定量EASL和定量ADC分别为R2 = 0.9657和R2 = 0.9662)和很强的方法间一致性(R2 = 0.9585)。与非3D技术相比(与视觉评估相比,RSE = 12.18),两种方法均显示出与病理学测量的坏死明显不同的误差(定量EASL和定量ADC的残留标准误[RSE]分别为6.38和6.33)。这项放射-病理学相关研究证明了3D定量MR成像技术在鉴定经TACE治疗的HCC病变中经病理学测量的肿瘤坏死的诊断准确性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号